当前位置: 首页 > 期刊 > 《中国现代医生》 > 2016年第9期
编号:12876326
慢性阻塞性肺疾病生物标记物的研究进展(5)
http://www.100md.com 2016年3月25日 《中国现代医生》 2016年第9期
     [34] Lomas DA,Silverman EK,Edwards LD,et al. Evaluation of serum CC-16 as a biomarker for COPD in the ECLIPSE cohort[J]. Thorax,2008,63(12):1058-1063.

    [35] Phye Yun,C Andrew,JL Wright,et al. Club cell protein 16 and disease progression in chronic obstructive pulmonary disease[J]. American Journal of Respiratory & Critical Care Medicine,2013,188(12):1413-1419.

    [36] Peng G,Jie Z,Xiaoyan H,et al. Sputum inflammatory cell-based classification of patients with acute exacerbation of chronic obstructive pulmonary disease[J]. Plos One,2013,8(5):e57678.

    [37] Brightling CE,Monteiro W,Ward R,et al. Sputum eo-sinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease:A randomised controlled trial[J]. Lancet,2000,356(9240):1480-1485.

    [38] Siva R,Green RH,Brightling CE,et al. Eosinophilic airway inflammation and exacerbations of COPD:A randomized controlled trial[J]. Eur Respir J,2007,29(5):906-913.

    [39] Bafadhel M,McKenna S,Terry S,et al. Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease:A randomized placebo-controlled trial[J]. Am J Respir Crit Care Med,2012,186(1):48-55.

    (收稿日期:2016-01-12), 百拇医药(邱海兵 冯起校)
上一页1 2 3 4 5